ArticleTranslational gastroenterology and hepatology2026
Safely targeting combination TNF and IL-23 using a gut-restricted and orally delivered therapeutic approach: proof-of-concept for the development of SOR102 in ulcerative colitis.
Ilaria Faggiani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.